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Abstract
BACKGROUND: Metastatic cervical cancer in the ureter may lead to obstructive uropathy due to mechanical ureteral 
blockage. The insertion of a double J (DJ) stent is a urinary diversion option that can be offered to the patients, but it 
becomes challenging due to the high rate of failures.
AIM: The aim of the study was to determine the factors that predict the success of DJ stent insertion in obstructive 
uropathy due to advanced cervical cancer.
MATERIALS AND METHODS: The patients studied were those with obstructive uropathy due to advanced cervical 
cancer from 2017 to 2020 in Sanglah General Hospital. The research subjects were divided into two groups: First 
were the samples of successful DJ stent insertions and the second were those that failed. In the analysis, the Chi-
square tests were used for categorical data, while the independent t-tests were used for normally distributed data. 
Logistic regression analyses which involved both the univariate and multivariate were conducted to determine the 
factors that aided the success of DJ stent insertions.
RESULTS: Retrograde stent insertion of DJ stents was conducted on 100 patients. Successful insertions were found 
in 57 patients (57%), while those that failed were observed in 43 subjects (43%). The results of multivariate regression 
analyses showed that low-grade hydronephrosis (odd ratios [OR] = 62.024; p = 0.000; confidence interval [CI] = 9.485–
405.596), normal albumin levels (OR = 5.856; p = 0.018; CI = 1.359–25.243), lower Federation of Gynecology and 
Obstetrics (FIGO) staging (OR = 14.985; p = 0.007; CI = 2.108–106.536), and a history of radiotherapy (OR = 8.758; 
p = 0.005; CI = 1.943–39.477) were the significant factors for predicting the success of DJ stent insertions.
CONCLUSION: Low-grade hydronephrosis, normal albumin levels, lower FIGO staging, and a history of radiotherapy 
are the strong factors for predicting the success of DJ stent insertions in obstructive uropathy due to advanced 
cervical cancer.
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Introduction
Cervical cancer is one of the most commonly 
found malignant diseases in women. Approximately 
500,000 new cases of cervical cancer are recorded 
each year and cause about 274,000 deaths per year 
worldwide. In Sanglah Hospital, there were 574 cases 
of cancer recorded from 2011 to 2015. More than 40% 
of the cervical cancer patients were already in advance 
stage and required urine diversion since they have 
been experiencing obstructive uropathy [1], [2], [3].
Metastatic cervical cancer in the ureter may 
lead to obstructive uropathy due to mechanical ureteral 
blockage. The pathological mechanisms in these 
regards include; encasement and concentric occlusion 
of the ureter by the metastatic tumor deposits, direct 
extrinsic pressure, vigorous fibroblastic reaction 
leading to stricture, and fibrosis formation resulting 
in obstructive angulation, or the invagination of the 
upper ureteral segment into the lower portion [4], [5]. 
Urinary diversion in cases of obstructive uropathy 
due to advanced cervical cancer is needed to prevent 
deteriorating kidney function and has been proven to 
increase the chance of survival [6], [7]. The insertion of a 
double J (DJ) stent and the percutaneous nephrostomy 
is urinary diversion options that can be offered to the 
patients. Although several studies have consistently 
discovered that percutaneous nephrostomy is slightly 
better in restoring kidney function, psychosocially, 
patients are more receptive to DJ stent insertion 
since it is generally accepted and may be left in place 
for long periods of time when necessary, without 
an external tube [7], [8], [9]. In palliative cases, the 
patient’s preference is respected in accordance with 
the medical options provided [2], [9]. DJ stent insertions 
in metastatic ureteral obstruction due to advanced 
cervical cancer are becoming challenging due to the 
high rate of failures [10]. Informed consent before a 
successful DJ stent installation, endoscopic equipment 
preparation, anesthetic factors, and the possibility of 
time extension due to insertion failure are the issues 
to consider. Therefore, this study aims to evaluate the 
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factors that predict the success of DJ stents insertion in 
obstructive uropathy due to advanced cervical cancer.
Materials and Methods
The subjects observed in this study were 
those who had obstructive uropathy due to cervical 
cancer from 2017 to 2020 and performed DJ stent 
insertion attempt in the Urology Department of Sanglah 
Hospital. DJ stent insertion was considered to be 
successful if it inserted properly in at least one side of 
the kidney. Pre-operative data collected, including the 
2D ultrasonography results, which showed the degree 
of hydronephrosis (classification of the Society of Fetal 
Ultrasound/SFU), cancer diameter, and the presence 
of cancer infiltration in the bladder. Laboratory data 
were collected, including blood urea nitrogen (BUN) 
levels, creatinine, and blood albumin. Other clinical 
data comprised the cervical cancer staging, based 
on the International Federation of Gynecology and 
Obstetrics (FIGO) classification and also a history of 
chemotherapy, radiotherapy, and surgery [11], [12]. 
Furthermore, the research subjects were divided into 
two groups: The first group is the one that succeeds in 
inserting the DJ stent, while the second group is those 
who fail. This study was analyzed using the Chi-square 
tests for categorical data, while the independent t-tests 
were used for distributed numerical data. Logistic 
regression analysis, which involves both the univariate 
and multivariate were carried out to determine the 
factors that aided the success of the DJ stents’ 
insertion. The odds ratios (OR) of each characteristic 
and the confidence interval (CI) were calculated to find 
significant differences. Data were analyzed using IBM 
SPSS software version 26.
Results
Table 1 summarized the characteristics and 
results of the univariate analysis that influenced the 
success of DJ stent insertions. Among the 100 patients, 
57 were successful, while 43 were fail. The average age 
of Group I was 50.35 ± 8.15 and Group II was 50.97 ± 
10.49. The degree of hydronephrosis of the two groups 
was evaluated using 2D ultrasonography and classified 
according to SFU standards. In Group I, the majority of 
the hydronephrosis were Grades 1 and 2, and in the 
reverse group, they were Grades 3 and 4 (Figure 1). 
The diameter of cancer and the bladder infiltration was 
identified through ultrasonography. In Group I, the mean 
diameter was determined as 3.34 ± 1.02 cm, while in 
Group II it was 6.31 ± 1.13 cm.
The laboratory results of Groups I and II were 
compared. The average BUN score for Group I was 
21.2 ± 15.42, while for Group II, it was 40.6 ± 29.06. 
The creatinine values for Groups I and II were 2.2 ± 2.4 
and 4.7 ± 4.4, respectively. The albumin level for Group 
I was 3.7 ± 0.7, while for Group II, it was 3.1 ± 0.7. The 
clinical stage of cervical cancer was classified according 
to FIGO, and the ultrasonography was conducted in 
the Radiology Department of Sanglah Hospital. The 
dominant clinical stage of the two groups was 3B, with 
47 (82.5%) patients in Group I and 39 (90.7%) in Group 
II, followed by Stage 4, in each group were 10 (17.5%) 
and 4 (9.3%), respectively.
Figure 1: Hydronephrosis grade in each group
Based on previous procedures history, 
each group was classified according to their 
treatment record, surgery (total abdominal salpingo-
oophorectomy hysterectomy), chemotherapy, and 
radiotherapy. Patients who were treated with TAH BSO 
were patients who initially had early cervical cancer 
(stages ≤2A) and further experienced recurrent and 
progression with concomitant obstructive uropathy. At 
our institution, many patients with advanced cervical 
cancer have to wait for radiotherapy queues and are 
given chemotherapy. The combination of carboplatin 
and paclitaxel is considered less toxic and had similar 
effectiveness compared to cisplatin and paclitaxel. 
In Group I, 42 (73%) patients were found a history 
of treatment procedures; only 1 (1.73%) performed 
Table 1: Patient characteristics and univariate analysis 
influenced the success of DJ stent insertion
Characteristic Success (Group I) n = 57 Failure (Group II) n = 43 p-value
Age 50.35 ± 8.15 50.97 ± 10.49 0.738a
Hydronephrosis 0.000b
Grade I 15 (26.3%) 0 (0%)
Grade II 25 (43.9%) 4 (9.3%)
Grade III 14 (24.6%) 21 (48.8%)
Grade IV 3 (5.3%) 18 (41.9%)
Cancer diameter 3.34 ± 1.02 6.31 ± 1.13 0.000a
Bladder infiltration n = 57 n = 43 0.009b
Yes 34 (59.6%) 36 (83.7%)
No 23 (40.4%) 7 (16.3%)
Laboratory findings
BUN level 21.2 ± 15.42 40.6 ± 29.06 0.000a
Creatinin level 2.2 ± 2.4 4.7 ± 4.4 0.001a
Albumin level 3.7 ± 0.7 3.1 ± 0.7 0.000a
Staging (FIGO) n = 57 n = 43 0.079b
Stage 3b 47 (82.5%) 39 (90.7%)
Stage 4 10 (17.5%) 4 (9.3%)
Medication history 0.004b
Operation 1 (1.73%) 5 (11.4%)
Chemotherapy 14 (24.3%) 12 (27.5%)
Radiotherapy 36 (62.5%) 10 (22.9%)
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surgery, 14 (24.3%) received chemotherapy, and 36 
(62.5%) performed radiotherapy. In Group II, 24 (55%) 
patients were found a history of treatment procedures; 
5 (11.5%) performed surgery, 12 (27.5%) received 
chemotherapy, and 10 (22.9%) performed radiotherapy. 
The characteristics of the pre-operative patients 
and the results of the univariate analysis showed that 
grade hydronephrosis (p = 0.000), cavity diameter 
(p = 0.000), bladder infiltration (p = 0.009), BUN levels 
(p = 0.000), creatinine (p = 0.001), albumin (p = 0.001), 
and history of surgery (p = 0.004) aided the success of 
DJ stent insertions, while the age and staging features 
were exceptions. The results of multivariate regression 
analysis of the factors that influenced the success of DJ 
stent insertions were illustrated in Table 2. Low-grade 
hydronephrosis (OR  =  62.024; p = 0.000; CI = 9.485–
405.596), albumin levels (OR = 5.856; p = 0.018; 
CI = 1.359–25.243), FIGO staging (OR = 14.985; 
p = 0.007; CI = 2.108–106.536), and history of 
radiotherapy (OR = 8.758; p = 0.005; CI = 1.943–39.477) 
were significant factors for predicting the success of DJ 
stent insertions (Table 2).
Table 2: Multivariate analysis of factors influenced the success 
in DJ stent insertion
Factors p-value OR 95% CI
USG findings
Lower grade hydronefrosis 0.000 62.024 9.485–405.596
Bladder infiltration 0.075 3.951 0.871–17.935
Laboratory findings
BUN level 0.233 2.291 0.586–8.951
Kreatinin level 0.675 1.525 0.212–10.963
Albumin level 0.018 5.865 1.359–25.243
FIGO staging 0.007 14.985 2.108–106.536
Radiotherapy history 0.005 8.758 1.943–39.477
Discussion
In this study, 43% of patients had unsuccessful 
DJ stent insertions which were caused mostly by the 
difficulty in locating the ureteric orifice. The second 
reason was due to the stricture and fibrosis of the distal 
ureteral and angulation which caused a severe blockage. 
Several studies reported that the percentage of failure 
from DJ stent insertions ranged from 16% to 58%, which 
was caused by urinary tract obstruction, resulting from 
cervical malignancies [9], [13]. The high unsuccessful 
DJ stent insertions were related to advanced-stage 
cervical cancer, where cellular infiltrations spread to the 
bladder and ureteral tissues [14]. The metastases of the 
ureter, which started with the periureteral infiltration by 
tumor cells, resulted in the compression of the ureteral 
wall. The transmural, muscular coat, perilymphatic, 
vascular layers, the mucosal, and submucosal nodules 
were also affected by the tumor cells [14], [15].
The findings of bladder and ureteral wall 
involvement by the metastases and hydronephrosis 
can be detected on radiography using USG. Bladder 
infiltrations were identified based on the morphological 
changes in its walls and mass indenting the base of 
the bladder [16]. The multivariate analysis showed 
that bladder involvement that was detected on 
ultrasonography was not a significant factor for 
predicting the success of DJ stent insertion. These 
results indicated that mechanical obstruction caused 
by metastasis cannot be easily assessed from USG. 
The weakness of this study was the use of conventional 
2D ultrasound. Although its accuracy was lower than 
that of transvaginal 3D, 2D was still used for screening 
infiltration of the bladder in advanced cervical cancer 
patients at our institution because it is more practical 
and cheaper compared to CT scans, MRI, and urine 
cytology [17]. From the results of multivariate analysis, 
it was concluded that low hydronephrosis grade was 
a strong predictor of the success of DJ stent insertion. 
The result of the OR hydronephrosis value was high, 
and was 62,024, according to the study conducted by 
Wang et al. [9], while those from both the univariate and 
multivariate analyses were 5.73 and 6.45, respectively. 
The grade of hydronephrosis was correlated to the 
degree of mechanical obstruction at the ureter; 
therefore, the heavier it is, the more difficult it is to insert 
the DJ stent.
The laboratory tests showed that BUN and 
creatinine levels in patients with successful DJ stent 
insertions were much lower than in those that failed. 
However, the results of the multivariate analysis 
indicated that BUN and creatinine levels were not 
significant predictors. This corresponds with the study 
conducted by Danilovic et al. [18], that serum pre-
operative creatinine had no influence in the insertion 
of DJ stents, but Wenzler et al. [19] stated that DJ 
stent insertion failure was attributed to male patients 
with high creatinine levels. Similar to Wenzler, 
Pedamallu [20] also confirmed the statement. The 
increased levels of BUN and creatinine were related 
to the degree of ureteral obstruction due to tumor 
infiltration, and bilateral ureteral obstruction resulted in 
decreased blood flow and glomerular filtration rate of 
both kidneys. This mechanism caused an increase in 
BUN and creatinine levels while decreasing the 24 h of 
urine production. Besides obstruction, there were other 
factors that caused the increased levels of BUN and 
creatinine in patients with advanced cervical cancer, 
which include: Dehydration, sepsis, history of diabetes 
or renal hypertension, and kidney diseases [21]. The 
laboratory results also indicated that low albumin 
levels were strong predictors of unsuccessful DJ 
stent insertions based on multivariate analysis. This 
corresponds with the research conducted by Yu 
et al. [22] and Yoon et al. [23] that hypoalbuminemia 
was associated with early failure of ureteral stent 
function. It was also observed that cancer patients had 
low serum albumin values, coupled with the presence 
of malnutrition and inflammation; therefore, those with 
hypoalbuminemia often have a progressive disease 
and worse prognosis. Giving albumin before DJ stent 
insertion will not increase the chance of successful DJ 
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stent insertion because the pathology of the ureter has 
already occurred due to cervical cancer progression.
There were two criteria for diagnosing 3B 
cervical cancer based on the current FIGO classification: 
Fixed tumor in the bladder wall beside the pelvic bone, 
or the presence of undefined hydronephrosis due 
to other factors. For determining Stage 4, it is tumor 
infiltration on the mucosa of the bladder, rectum, or 
pelvic bone [12]. The clinical classification based on 
FIGO criteria was a strong predictor of DJ stent insertion 
since the lower the cancer stage, the higher the insertion 
success level. This was also in correspondence with a 
study conducted by Soetojo [2] that the level of stent 
insertions in the ipsilateral kidney with hydronephrosis 
depends on the clinical stage of cervical cancer.
Previous studies conducted by Chung 
et al. [24] and Chitale et al. [25] did not determine the 
history of radiotherapy as a predictor. In this study, DJ 
stents were easily inserted in patients that underwent 
radiation therapy and correspond with the research 
conducted by Liu et al. [26], which stated that cervical 
cancer patients that had been previously radiated had 
lower disease progression and higher survival rates. 
The effect shrunk the heavy tumor pressing on the 
ureter wall, thus used in the early stages of the disease.
Conclusion
Low-grade hydronephrosis, normal albumin 
levels, lower FIGO staging, and a history of radiotherapy 
are the strong factors for predicting the success of DJ 
stent insertions in obstructive uropathy due to advanced 
cervical cancer.
References
1. Darmayasa IM, Made BD, Hari WS. Kualitas Hidup Pasien 
Kanker Serviks Yang Dirawat di Ruang Cempaka Ginekologi 
RSUP Sanglah Denpasar. Jakarta: Disampaikan Pada PIT 
HOGSI X; 2017. https://doi.org/10.15562/medicina.v50i2.822
2. Soetojo S, Nurdin AT. Charateristics of gynecological 
abnormalities and types of urine diversion at Dr Soetomo 
Hospital, Surabaya, Indonesia, in three-year period. Fol 
Med Indones. 2019;55:134-8. https://doi.org/10.20473/fmi.
v55i2.14347
3. Oktaviani BD, Sriwidyani NP, Sumadi IW. Karakteristik 
klinikopatologi penderita kanker serviks uteri berdasarkan data 
di laboratorium patologi anatomi RSUP Sanglah Denpasar 
Tahun 2011-2015. E J Med Udayana. 2018;7(8):1-6. https://doi.
org/10.35790/ecl.8.1.2020.27814
4. Cohen WM, Freed SZ, Hasson J. Metastatic cancer to the 
ureter: A review of the literature and case presentations. J Urol. 
1974;112(2):188-9. https://doi.org/10.1016/s0022-5347(17)59679-2
 PMid:4843329
5. Arvind NK, Singh O, Gupta S, Ali Q. Ureteral metastasis as the 
presenting manifestation of pancreatic carcinoma. Rev Urol. 
2013;15(3):124-30.
 PMid:24223025
6. Kouba E, Wallen EM, Pruthi RS. Management of ureteral 
obstruction due to advanced malignancy: Optimizing therapeutic 
and palliative outcomes. J Urol. 2018;180(2):444-50. https://doi.
org/10.1016/j.juro.2008.04.008
 PMid:18550089
7. Tan S, Tao Z, Bian X, Zhao Y, Wang N, Chen X, et al. Ureteral 
stent placement and percutaneous nephrostomy in the 
management of hydronephrosis secondary to cervical cancer. 
Eur J Obstet Gynecol Reprod Biol. 2019;241:99-103. https://doi.
org/10.1016/j.ejogrb.2019.08.020
 PMid:31484100
8. Ahmad I, Pansota MS, Tariq M, Saleem MS, Tabassum SA, 
Hussain A. Comparison between Double J (DJ) ureteral stenting 
and Percutaneous Nephrostomy (PCN) in obstructive uropathy. 
Park J Med Sci. 2013;29(3):725-9. https://doi.org/10.12669/
pjms.293.3563
 PMid:24353616
9. Wang JY, Zhang HL, Zhu Y, Qin XJ, Dai B, Ye DW. Predicting 
the failure of retrograde ureteral stent insertion for managing 
malignant ureteral obstruction in outpatients. Oncol Lett. 
2016;11(1):879-83. https://doi.org/10.3892/ol.2015.3961
 PMid:26870299
10. Noegroho BS, Mustafa A. Predictive factor for successful 
retrograde ureteral stent insertion in obstructive uropathy due 
to advanced cervical cancer. Urogynaecologia. 2019;31(1):221. 
https://doi.org/10.4081/uij.2019.221
11. Fernbach SK, Maizels M, Conway JJ. Ultrasound grading of 
hydronephrosis: Introduction to the system used by the society 
for fetal urology. Pediatr Radiol. 1993;23(6):478-80. https://doi.
org/10.1007/bf02012459
 PMid:8255658
12. Sobin LH, Wittekind L. International Union Against Cancer 
(UICC) TNM Classification of Malignant Tumours. 6th ed. 
Hoboken, NJ: Wiley; 2002. p. 155-7.
13. Chan ES, Matsuda T. Endourology Progress Technique, 
Technology and Training. Singapore: Springer Nature; 2019.
14. Yamagami T, Ide K, Nishio K. Studies on the pathophysiology 
of ureteral lesion in treatment for the uterine cervical cancer. 
Kurume Med J. 1973;20(2):113-8. https://doi.org/10.2739/
kurumemedj.20.113
15. Singh I, Strandhoy JW, Assimos DG. Pathophysiology of 
urinary tract obstruction. In: Campbell-Walsh Urology. 10th ed. 
Philadelphia, PA: Elsevier Saunders; 2012. p. 1087-120. https://
doi.org/10.1016/b978-1-4160-6911-9.00040-2
16. Huang WC, Yang JM, Yang YC, Dan Yang SH. Ultrasonographic 
characteristics and cystoscopic correlates of bladder wall 
invasion by endophytic cervical cancer. Ultrasound Obstet 
Gynecol. 2006;27(6):680-6. https://doi.org/10.1002/uog.2775
 PMid:16710879
17. Chou CY, Hsu KF, Wang ST, Huang SC, Tzeng CC, 
Huang KE. Accuracy of three-dimensional ultrasonography 
in volume estimation of cervical carcinoma. Gynecol Oncol. 
1997;66(1):89-93. https://doi.org/10.1006/gyno.1997.4714
18. Danilovic A, Antonopoulos IM, Mesquita JL, Lucon AM. 
Likelihood of retrograde double-J stenting according to ureteral 
obstructing pathology. Int Braz J Urol. 2005;31(5):431-6. https://
doi.org/10.1590/s1677-55382005000500003
19. Wenzler DL, Kim SP, Rosevear HM, Faerber GJ, Roberts WW, 
Wolf JS. Success of ureteral stents for intrinsic ureteral obstruction. J 
Endourol. 2008;22:295-9. https://doi.org/10.1089/end.2007.0201 
PMid:18294036
B - Clinical Sciences Surgery
886 https://www.id-press.eu/mjms/index
20. Pedamallu R, Subramanian S. Factors predicting success rate 
of retrograde ureteric stenting in managing patients with ureteric 
obstruction-our experiences in a South Indian tertiary institute. 
Internet J Urol. 2015;14(1):1-7.
21. Higgins C. Urea and the Clinical Value Measuring Blood Urea 
Concentration. Available from: http://www.acutecaretesting.org. 
[Last accessed on 2020 May 23].
22. Yu SH, Ryu JG, Jeong SH, Hwang EC, Jang WS, Hwang IS, 
et al. Predicting factors for stent failure-free survival in 
patients with a malignant ureteral obstruction managed with 
ureteral stents. Korean J Urol. 2013;54(5):316-21. https://doi.
org/10.4111/kju.2013.54.5.316
 PMid:23700497
23. Yoon JH, Park S, Moon KH, et al. Renal function is associated 
with prognosis in stent-change therapy for malignant ureteral 
obstruction. Investig Clin Urol. 2018;59(6):376-82. https://doi.
org/10.4111/icu.2018.59.6.376
 PMid:30402570
24. Chung SY, Stein RJ, Landsittel D, Davies BJ, Cuellar DC, 
Hrebinko RL, et al. 15-year experience with the management 
of extrinsic ureteral obstruction with indwelling ureteral 
stents. J Urol. 2004;172(2):592-5. https://doi.org/10.1097/01.
ju.0000130510.28768.f5
 PMid:15247739
25. Chitale SV, Scott-Barrett S, Ho ET, Burgess NA. The 
management of ureteric obstruction secondary to malignant 
pelvic disease. Clin Radiol. 2002;57(12):1118-21. https://doi.
org/10.1053/crad.2002.1114
 PMid:12475538
26. Liu YM, Ni LQ, Wang SS, Lv QL, Chen WJ, Ying SP. Outcome 
and prognostic factors in cervical cancer patients treated with 
surgery and concurrent chemoradiotherapy: A retrospective 
study. World J Surg Oncol. 2018;16:18. https://doi.org/10.1186/
s12957-017-1307-0
 PMid:29378625
